The ErbB4 CYT2 variant protects EGFR from ligand-induced degradation to enhance cancer cell motility
暂无分享，去创建一个
B. Kholodenko | A. Tutt | S. Pinder | M. Simpson | A. Plückthun | Y. Yarden | B. Burford | J. Monypenny | D. Dafou | P. Parker | Y. Boersma | T. Ng | S. Ameer-Beg | O. Coban | M. Martin-Fernandez | W. Gullick | M. Winn | C. Gillett | S. Poland | D. Matthews | G. Fruhwirth | K. Lawler | D. Rolfe | T. Kiuchi | E. de Rinaldis | P. Marra | V. Devauges | G. Santis | N. Woodman | E. Ortiz-Zapater | L. Nguyen | J. Barbeau | Brian Burford | Natalie Woodman | Elena Ortiz-Zapater